Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IFB-H5253 | Human | Human IFN-alpha 2b Protein, Fc Tag (MALS verified) |  |
|
|
Human IFN-alpha 2b, Fc Tag (Cat. No. IFB-H5253) immobilized on CM5 Chip can bind Human IFNAR2, His Tag (Cat. No. IF2-H5224) with an affinity constant of 0.257 μM as determined in SPR assay (Biacore T200) (Routinely tested).
The purity of Human IFN-alpha 2b, Fc Tag (Cat. No. IFB-H5253) is more than 90% and the molecular weight of this protein is around 95-105 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Nadofaragene firadenovec | SCH-721015 | Approved | Schering - Plough Sa, Fkd Therapies | Adstiladrin | United States | Urinary Bladder Neoplasms | Ferring Pharmaceuticals A/S | 2022-12-16 | Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Mesothelioma | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Autologous CD34+-enriched hematopoietic stem and progenitor cells (Genenta Science) | Phase 2 Clinical | Genenta Science Srl | Carcinoma, Renal Cell; Glioblastoma; Multiple Myeloma | Details | |
| SFR-1882 | SFR-1882 | Phase 1 Clinical | Tianjin Sinobiotech Ltd | Anemia; Renal Insufficiency | Details |
| CX-801 | CX-801 | Phase 1 Clinical | Cytomx Therapeutics Inc | Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Melanoma | Details |
| interferon-alpha2b (The University Health Network) | Clinical | University Health Network (Uhn) | Coronavirus Disease 2019 (COVID-19) | Details |
This web search service is supported by Google Inc.
A-Z
